Extended treatment of tumors through vessel occlusion with light activated drugs

• US 20090192209A1
• Filed: 01/07/2005
• Published: 07/30/2009
• Est. Priority Date: 09/24/2004
• Status: Abandoned Application

• Current Assignee: Light Sciences Oncology, Inc.
• Original Assignee: Light Sciences Oncology, Inc.
• Inventors: Xu, Hongxia, Winship, Myron Jay, Krouse, Michael Alan, Liang, Yan, Mahoney, Paula A.
• Application Number:
  US11/663,695
• Publication Number:
  US 20090192209A1
• Time in Patent Office: Days
• US Class Current: 514/410
• CPC Class Codes: A61K 41/0057 Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
• CPC Class Codes: A61K 41/0071 PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
• CPC Class Codes: A61K 41/0076 PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
• CPC Class Codes: A61P 35/00 Antineoplastic agents

Abstract

Methods of treating diseases of a subject through selective occlusion of blood vessels. The methods include identifying and/or mapping the blood vessels supplying nutrients to the diseased or unwanted tissue, delivering an appropriate dose of an occlusion-forming photosensitizer to the subject, and exciting the photosensitizer with sufficient light irradiation in the vicinity of the blood vessels to cause vessel occlusion. The vessel occlusion cuts off nutrient supply to the diseased or unwanted tissue resulting in cell death of that tissue and any other tissue served by the occluded vessels.

Claims

1. A method of treating a subject having a condition susceptible to treatment through occlusion of blood vessels, the treatment comprising:

a) identifying at least one blood vessel to be occluded;

b) selecting a photosensitizer that occludes blood vessels upon excitation with an appropriate wavelength of radiation;

c) delivering to the subject a dose of the photosensitizer, sufficient to cause vessel occlusion after excitation; and

d) exciting photosensitizer in the vicinity of the blood vessel with an appropriate light wavelength for a sufficient period of time to cause occlusion of the blood vessel.

2. The method of claim 1, wherein the identifying comprises locating a position of the at least one vessel.

3. The method of claim 1, wherein the selecting comprises selecting any one of the photosensitizers from the group consisting of Talaporfin Sodium, verteporfin, and rostaporfin.

4. The method of claim 3, wherein the photosensitizer is Talaporfin Sodium and the wavelength of the exciting is about 664 nm.

5. The method of claim 1, wherein the blood vessel supplies nutrients to tissue to be treated.

6. The method of claim 1, wherein the at least one blood vessel supplies nutrient to one tumor.

7. The method of claim 1, wherein the identified at least one vessel is a supplier of blood to multiple tumors.

8. A method of treating diseased tissue in a subject, the treatment comprising:

a) identifying diseased or unwanted tissue and at least one blood vessel supplying the tissue;

b) selecting a photosensitizer that occludes blood vessels upon excitation with an appropriate wavelength of radiation;

c) delivering to the subject a therapeutically effective dose of the photosensitizer; and

d) exciting the photosensitizer in the vicinity of the blood vessel for a sufficient period of time to cause occlusion of the blood vessel;

whereby occlusion of the blood vessel results in beneficial treatment of the diseased or unwanted tissue and cell death of other tissue served by the same blood vessel.

9. The method of claim 8, wherein the identifying comprises locating a position of the at least one vessel.

10. The method of claim 8, wherein the selecting comprises selecting any one of the photosensitizers from the group consisting of Talaporfin Sodium, verteporfin, and rostaporfin.

11. The method of claim 10, wherein the photosensitizer is Talaporfin Sodium and the wavelength of the exciting is about 664 nm.

12. The method of claim 8, wherein the blood vessel sup plies nutrients to tissue to be treated.

13. The method of claim 8, wherein the at least one blood vessel supplies nutrient to diseased tissue comprising at least one tumor.

14. The method of claim 8, wherein the identified at least one vessel is a supplier of blood to an organ comprising multiple tumors.

15. A method of treating an extended area of a body organ of a subject using photodynamic therapy, the organ containing a plurality of tumors, the method comprising:

a) identifying the extended area of the organ containing a plurality of tumors, and at least one major blood vessel supplying the extended area and tumors therein;

b) selecting a photosensitizer that occludes blood vessels upon excitation with an appropriate wavelength of radiation;

c) delivering to the subject a therapeutically effective dose of the photosensitizer; and

d) exciting the photosensitizer around the identified major blood vessel for a sufficient period of time to cause occlusion of the identified blood vessel.

16. The method of claim 15, wherein the identifying comprises locating a position of the at least one major vessel.

17. The method of claim 15, wherein the selecting comprises selecting any one of the photosensitizers from the group consisting of Talaporfin Sodium, verteporfin, and rostaporfin.

18. The method of claim 15, wherein the photosensitizer is Talaporfin Sodium and the wavelength of the exciting is about 664 nm.

19. The method of claim 15, wherein occlusion of the major blood vessel results in cell death of tumor cells and also of healthy tissue within the extended area.